These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 10765096)
1. Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation. Lipponen P; Aaltomaa S; Kellokoski J; Ala-Opas M; Kosma V Eur Urol; 2000 May; 37(5):573-8. PubMed ID: 10765096 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer. Aaltomaa S; Lipponen P; Eskelinen M; Ala-Opas M; Kosma VM Prostate; 1999 Apr; 39(1):8-15. PubMed ID: 10221260 [TBL] [Abstract][Full Text] [Related]
3. Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival. Aaltomaa S; Eskelinen M; Lipponen P Prostate; 1999 Feb; 38(3):175-82. PubMed ID: 10068341 [TBL] [Abstract][Full Text] [Related]
4. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression. Baretton GB; Klenk U; Diebold J; Schmeller N; Löhrs U Br J Cancer; 1999 May; 80(3-4):546-55. PubMed ID: 10408865 [TBL] [Abstract][Full Text] [Related]
5. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis. Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624 [TBL] [Abstract][Full Text] [Related]
6. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer. Ruiz M; Troncoso P; Bruns C; Bar-Eli M Clin Cancer Res; 2001 Dec; 7(12):4086-95. PubMed ID: 11751506 [TBL] [Abstract][Full Text] [Related]
7. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053 [TBL] [Abstract][Full Text] [Related]
8. WAF1/p21 protein expression is an independent prognostic indicator in superficial and invasive bladder cancer. Korkolopoulou P; Konstantinidou AE; Thomas-Tsagli E; Christodoulou P; Kapralos P; Davaris P Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):285-92. PubMed ID: 11127920 [TBL] [Abstract][Full Text] [Related]
10. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines. Sugibayashi R; Kiguchi Y; Shimizu T; Suzuki T; Hamada H; Takeda K Anticancer Res; 2002; 22(2A):713-9. PubMed ID: 12014641 [TBL] [Abstract][Full Text] [Related]
12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
13. Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer. Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Kosma VM Br J Cancer; 1999 May; 80(3-4):477-82. PubMed ID: 10408856 [TBL] [Abstract][Full Text] [Related]
14. Mutated p53 protein expression and proliferative activity in advanced gastric cancer. Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058 [TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. Aaltoma SH; Lipponen PK; Kosma VM Anticancer Res; 2001; 21(4B):3101-6. PubMed ID: 11712818 [TBL] [Abstract][Full Text] [Related]
16. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer. Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097 [TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up. Caffo O; Doglioni C; Veronese S; Bonzanini M; Marchetti A; Buttitta F; Fina P; Leek R; Morelli L; Palma PD; Harris AL; Barbareschi M Clin Cancer Res; 1996 Sep; 2(9):1591-9. PubMed ID: 9816338 [TBL] [Abstract][Full Text] [Related]
19. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639 [TBL] [Abstract][Full Text] [Related]
20. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]